The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Jacquie Chirgwin, Zhuoxin Sun, Ian Smith, Karen N Price, Beat Thurlimann, Bent Ejlertsen, Herve Bonnefoi, Meredith M Regan, Aron Goldhirsch, Alan S Coates

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)295 - 306
Number of pages12
JournalBreast Cancer Research and Treatment
Issue number1
Publication statusPublished - 2012

Cite this